You have 9 free searches left this month | for more free features.

Overall Status

Recruiting (15)

Not yet recruiting (9)

Completed (2)

Active, not recruiting (1)

Withdrawn (1)

Sign in for free

Phase

phase 2 (9)

phase 1 (6)

phase 1/phase 2 (6)

phase 3 (4)

early phase 1 (1)

Study Documents

Intervention Type

drug (26)

biological (2)

procedure (1)

Funder Type

Industry (14)

Other (14)

Study Type

Interventional (26)

Observational (2)

Iberdomide

Showing 26 - 28 of 28

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Systemic Lupus Erythematosus Trial in United States (CC-220, Placebo)

Completed

Systemic Lupus Erythematosus

CC-220
Placebo

Birmingham, Alabama
+34 more

Mar 5, 2020

Healthy Trial in Madison (CC-220 0.03 mg, CC-220 0.1 mg, CC-220 0.3 mg)

Completed

Healthy

CC-220 0.03 mg
+6 more

Madison, Wisconsin

Covance Clinical Research Unit

Nov 7, 2019

Incidence of Cereblon in Intensive Care Patients

Not yet recruiting

Critical Illness
Sepsis

(no location specified)

Oct 6, 2021